Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
1.910
+0.330 (20.89%)
At close: Jun 3, 2025, 4:00 PM
1.958
+0.048 (2.53%)
After-hours: Jun 3, 2025, 7:59 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $71.96 million as of June 3, 2025. Its market cap has decreased by -73.86% in one year.
Market Cap
71.96M
Enterprise Value
-42.81M
1-Year Change
-73.86%
Ranking
Category
Stock Price
$1.91
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $71.96M, a decrease of -85.26%. That is a compound annual growth rate of -38.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2025 | 59.52M | -78.35% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |